These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26105975)

  • 1. Association between nonalcoholic fatty liver disease and bone mineral density: a systematic review and meta-analysis.
    Upala S; Sanguankeo A; Jaruvongvanich V
    J Endocrinol Invest; 2015 Aug; 38(8):931-2. PubMed ID: 26105975
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?
    Targher G; Lonardo A; Rossini M
    J Endocrinol Invest; 2015 Aug; 38(8):817-25. PubMed ID: 26003827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic Fatty Liver Disease and Bone Mineral Density in Children and Adolescents: Specific Considerations for Future Studies.
    Mantovani A
    Dig Dis Sci; 2019 Mar; 64(3):898-900. PubMed ID: 30430297
    [No Abstract]   [Full Text] [Related]  

  • 4. Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with non-alcoholic fatty liver disease.
    Kim G; Kim KJ; Rhee Y; Lim SK
    PLoS One; 2017; 12(7):e0182202. PubMed ID: 28759632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: nonalcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density.
    Bidhendi Yarandi R
    Aliment Pharmacol Ther; 2019 Apr; 49(7):960-961. PubMed ID: 30868628
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults.
    Lee SH; Yun JM; Kim SH; Seo YG; Min H; Chung E; Bae YS; Ryou IS; Cho B
    J Endocrinol Invest; 2016 Nov; 39(11):1329-1336. PubMed ID: 27561910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease and osteoporosis: a systematic review and meta-analysis.
    Upala S; Jaruvongvanich V; Wijarnpreecha K; Sanguankeo A
    J Bone Miner Metab; 2017 Nov; 35(6):685-693. PubMed ID: 27928661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone mineral density in patients with liver cirrhosis].
    Topcheeva ON; Drozdov VN; Embutnieks IuV; Viazhevich IuV
    Eksp Klin Gastroenterol; 2009; (8):51-5. PubMed ID: 20469679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle.
    Poggiogalle E; Donini LM; Lenzi A; Chiesa C; Pacifico L
    World J Gastroenterol; 2017 Mar; 23(10):1747-1757. PubMed ID: 28348479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease.
    Pacifico L; Andreoli GM; D'Avanzo M; De Mitri D; Pierimarchi P
    World J Gastroenterol; 2018 May; 24(19):2073-2082. PubMed ID: 29785076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone metabolism and the cardiometabolic syndrome: pathophysiologic insights.
    McFarlane SI
    J Cardiometab Syndr; 2006; 1(1):53-7. PubMed ID: 17675897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone metabolism disorders and avascular bone necrosis: a further problem in HIV-infected patients?].
    Gutiérrez Rodero F; Padilla Urrea S
    Med Clin (Barc); 2002 Jun; 119(3):103-8. PubMed ID: 12106539
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone metabolism in non-alcoholic fatty liver disease: vitamin D status and bone mineral density.
    Eshraghian A
    Minerva Endocrinol; 2017 Jun; 42(2):164-172. PubMed ID: 27973461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers.
    Anavi S; Madar Z; Tirosh O
    Redox Biol; 2017 Oct; 13():386-392. PubMed ID: 28667907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone mineral density in patients with celiac disease and medical treatment of the disorder].
    Albulova EA; Drozdov VN; Parfenov AI
    Eksp Klin Gastroenterol; 2011; (3):25-30. PubMed ID: 21695949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications.
    Miele L; Targher G
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1243-5. PubMed ID: 26224399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Smoking & Bone.].
    Watanabe R; Inoue D
    Clin Calcium; 2016; 26(10):1445-1450. PubMed ID: 27666692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between nonalcoholic fatty liver disease and metabolic comorbidities.
    Zhao Q; Tang X; Wu J
    Hepatology; 2018 Jun; 67(6):2474. PubMed ID: 29251795
    [No Abstract]   [Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome.
    Lonardo A; Ballestri S; Marchesini G; Angulo P; Loria P
    Dig Liver Dis; 2015 Mar; 47(3):181-90. PubMed ID: 25739820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis.
    Musso G; Cassader M; Paschetta E; Gambino R
    Gastroenterology; 2018 Aug; 155(2):282-302.e8. PubMed ID: 29906416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.